| Announce Date | 12/04/2025 |
| EPS Normalized Actual | $1.05 (Beat by $0.02) |
| EPS GAAP Actual | $1.05 (Beat by $0.02) |
| Revenue Actual | $33.859B |
| Revenue Surprise | Beat by $33859M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Feb 2030 | 5.85 | 11.98 | 5.7048 | 6.07465 | 1 |
| Feb 2030 | 5.85 | 11.98 | 5.70443 | 6.07427 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | -2.02 | -2.02 | 33.859B | 0.66% | 33859M |
| FQ3 2025 (Aug 2025) | 0.92 | 0.92 | 33.94B | 100% | 33940M |
| FQ2 2025 (May 2025) | 3.74 | 3.74 | -0.011B | 100% | -11M |
| FQ1 2025 (Feb 2025) | 0.9 | 0.9 | 34.308B | 100% | 34308M |
| FQ4 2024 (Nov 2024) | 0.85 | 0.85 | 33.634B | 100% | 33634M |
| FQ3 2023 (Jul 2023) | -0.25 | -0.25 | 33.853B | 100% | 33853M |
| FQ2 2023 (Apr 2023) | 1.33 | 1.33 | 45.165B | 100% | 45165M |
| FQ1 2023 (Jan 2023) | 0.62 | 0.62 | 34.823B | 100% | 34823M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2030 (Nov 2030) | 1.44663 | -- | 1.41942 | 1.47277 | 7 |
| FQ3 2030 (Aug 2030) | 1.26416 | -- | 1.24038 | 1.287 | 7 |
| FQ2 2030 (May 2030) | 1.25285 | -- | 1.22928 | 1.27549 | 7 |
| FQ1 2030 (Feb 2030) | 1.801 | -- | 1.76712 | 1.83354 | 7 |
| FQ4 2029 (Nov 2029) | 1.32484 | -- | 1.29992 | 1.34878 | 7 |
| FQ3 2029 (Aug 2029) | 1.15638 | -- | 1.13463 | 1.17727 | 7 |
| FQ2 2029 (May 2029) | 1.13713 | -- | 1.11574 | 1.15768 | 7 |
| FQ1 2029 (Feb 2029) | 1.68793 | -- | 1.65618 | 1.71843 | 7 |
| FQ4 2028 (Nov 2028) | 1.2125 | -- | 1.1855 | 1.23292 | 11 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2030 (Nov 2030) | 37.07B | -- | 36.53B | 37.59B | 4 |
| FQ3 2030 (Aug 2030) | 35.43B | -- | 34.92B | 35.92B | 4 |
| FQ2 2030 (May 2030) | 35.33B | -- | 34.82B | 35.82B | 4 |
| FQ1 2030 (Feb 2030) | 47.1B | -- | 46.42B | 47.75B | 4 |
| FQ4 2029 (Nov 2029) | 35.94B | -- | 35.42B | 36.44B | 4 |
| FQ3 2029 (Aug 2029) | 34.72B | -- | 34.22B | 35.21B | 4 |
| FQ2 2029 (May 2029) | 34.57B | -- | 34.07B | 35.05B | 4 |
| FQ1 2029 (Feb 2029) | 45.91B | -- | 45.25B | 46.55B | 4 |
| FQ4 2028 (Nov 2028) | 35.05B | -- | 34.45B | 35.5B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | -2.02 | -2.02 | 100% | |
| FQ3 2025 (Aug 2025) | 0.92 | 0.92 | 100% | |
| FQ2 2025 (May 2025) | 3.74 | 3.74 | 100% | |
| FQ1 2025 (Feb 2025) | 0.9 | 0.9 | 100% | |
| FQ4 2024 (Nov 2024) | 0.85 | 0.85 | 100% | |
| FQ3 2023 (Jul 2023) | -0.25 | -0.25 | 100% | |
| FQ2 2023 (Apr 2023) | 1.33 | 1.33 | 100% | |
| FQ1 2023 (Jan 2023) | 0.62 | 0.62 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $33.86B | $33859M | 100% |
| FQ3 2025 (Aug 2025) | $0B | $33.94B | $33940M | 100% |
| FQ2 2025 (May 2025) | $0B | $-0.01B | $-11M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $34.31B | $34308M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $33.63B | $33634M | 100% |
| FQ3 2023 (Jul 2023) | $0B | $33.85B | $33853M | 100% |
| FQ2 2023 (Apr 2023) | $0B | $45.17B | $45165M | 100% |
| FQ1 2023 (Jan 2023) | $0B | $34.82B | $34823M | 100% |